Neurocrine Biosciences
NBIX
#1469
Rank
A$21.85 B
Marketcap
A$219.23
Share price
2.23%
Change (1 day)
1.23%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company